HEADER ANTIBIOTIC, HORMONE 29-JAN-09 2KEF TITLE SOLUTION NMR STRUCTURES OF HUMAN HEPCIDIN AT 325K COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPCIDIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HEPCIDIN-25, UNP RESIDUES 60-84; COMPND 5 SYNONYM: LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE, LEAP-1, LIVER TUMOR COMPND 6 REGRESSOR, PLTR, HEPCIDIN-25, HEPC25; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HAMP, HEPC, LEAP1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PDSRA21; SOURCE 9 OTHER_DETAILS: AMGEN PROPRIETARY VECTOR KEYWDS HEPCIDIN, ANTIBIOTIC, ANTIMICROBIAL, CLEAVAGE ON PAIR OF BASIC KEYWDS 2 RESIDUES, DISEASE MUTATION, FUNGICIDE, HORMONE, SECRETED EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.B.JORDAN,L.POPPE,M.HAINU,T.ARVEDSON,R.SYED,V.LI,H.KOHNO,H.KIM, AUTHOR 2 L.P.MIRANDA,J.CHEETHAM,B.J.SASU REVDAT 5 30-OCT-24 2KEF 1 REMARK REVDAT 4 16-MAR-22 2KEF 1 REMARK REVDAT 3 13-OCT-09 2KEF 1 JRNL REVDAT 2 08-SEP-09 2KEF 1 JRNL REVDAT 1 23-JUN-09 2KEF 0 JRNL AUTH J.B.JORDAN,L.POPPE,M.HANIU,T.ARVEDSON,R.SYED,V.LI,H.KOHNO, JRNL AUTH 2 H.KIM,P.D.SCHNIER,T.S.HARVEY,L.P.MIRANDA,J.CHEETHAM,B.J.SASU JRNL TITL HEPCIDIN REVISITED, DISULFIDE CONNECTIVITY, DYNAMICS, AND JRNL TITL 2 STRUCTURE. JRNL REF J.BIOL.CHEM. V. 284 24155 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19553669 JRNL DOI 10.1074/JBC.M109.017764 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA, CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KEF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1000101018. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 325 REMARK 210 PH : 3 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM HEPCIDIN-1, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-13C HSQC; REMARK 210 2D TOCSY-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 14 45.64 34.52 REMARK 500 1 HIS A 15 62.74 61.77 REMARK 500 1 ARG A 16 78.05 -153.51 REMARK 500 1 LYS A 18 -81.92 -51.17 REMARK 500 1 CYS A 19 116.95 177.95 REMARK 500 2 HIS A 3 84.84 63.41 REMARK 500 2 PHE A 4 87.44 51.97 REMARK 500 2 CYS A 14 42.46 36.39 REMARK 500 2 HIS A 15 60.79 64.30 REMARK 500 2 ARG A 16 78.43 -150.54 REMARK 500 2 LYS A 18 -82.36 -50.79 REMARK 500 2 CYS A 19 115.90 177.40 REMARK 500 3 THR A 2 67.51 64.11 REMARK 500 3 CYS A 14 45.44 34.53 REMARK 500 3 HIS A 15 62.66 62.00 REMARK 500 3 ARG A 16 78.04 -153.37 REMARK 500 3 LYS A 18 -81.88 -51.19 REMARK 500 3 CYS A 19 116.71 177.78 REMARK 500 4 CYS A 14 45.66 34.45 REMARK 500 4 HIS A 15 62.93 61.56 REMARK 500 4 ARG A 16 78.34 -153.45 REMARK 500 4 LYS A 18 -82.26 -51.10 REMARK 500 4 CYS A 19 115.93 177.55 REMARK 500 5 CYS A 14 42.46 36.22 REMARK 500 5 HIS A 15 60.70 64.35 REMARK 500 5 ARG A 16 78.48 -150.54 REMARK 500 5 LYS A 18 -82.30 -50.86 REMARK 500 5 CYS A 19 116.02 177.37 REMARK 500 6 CYS A 14 42.58 36.30 REMARK 500 6 HIS A 15 60.79 64.18 REMARK 500 6 ARG A 16 78.53 -150.67 REMARK 500 6 LYS A 18 -82.44 -50.88 REMARK 500 6 CYS A 19 116.26 177.33 REMARK 500 7 CYS A 14 42.46 36.25 REMARK 500 7 HIS A 15 60.68 64.38 REMARK 500 7 ARG A 16 78.28 -150.62 REMARK 500 7 LYS A 18 -82.44 -51.00 REMARK 500 7 CYS A 19 116.34 177.26 REMARK 500 8 CYS A 14 42.40 36.38 REMARK 500 8 HIS A 15 60.76 64.35 REMARK 500 8 ARG A 16 78.52 -150.75 REMARK 500 8 LYS A 18 -82.51 -50.81 REMARK 500 8 CYS A 19 116.23 177.32 REMARK 500 9 CYS A 14 42.59 36.31 REMARK 500 9 HIS A 15 60.80 64.21 REMARK 500 9 ARG A 16 78.36 -150.69 REMARK 500 9 LYS A 18 -81.73 -50.84 REMARK 500 9 CYS A 19 116.21 176.96 REMARK 500 10 CYS A 14 45.15 35.06 REMARK 500 10 HIS A 15 62.05 61.12 REMARK 500 REMARK 500 THIS ENTRY HAS 107 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2KEF A 1 25 UNP P81172 HEPC_HUMAN 60 84 SEQRES 1 A 25 ASP THR HIS PHE PRO ILE CYS ILE PHE CYS CYS GLY CYS SEQRES 2 A 25 CYS HIS ARG SER LYS CYS GLY MET CYS CYS LYS THR SHEET 1 A 2 CYS A 7 CYS A 10 0 SHEET 2 A 2 GLY A 20 CYS A 23 -1 O GLY A 20 N CYS A 10 SSBOND 1 CYS A 7 CYS A 23 1555 1555 1.95 SSBOND 2 CYS A 10 CYS A 13 1555 1555 1.93 SSBOND 3 CYS A 11 CYS A 19 1555 1555 1.95 SSBOND 4 CYS A 14 CYS A 22 1555 1555 2.12 CISPEP 1 PHE A 4 PRO A 5 1 0.00 CISPEP 2 PHE A 4 PRO A 5 2 -0.10 CISPEP 3 PHE A 4 PRO A 5 3 0.05 CISPEP 4 PHE A 4 PRO A 5 4 -0.03 CISPEP 5 PHE A 4 PRO A 5 5 -0.03 CISPEP 6 PHE A 4 PRO A 5 6 0.10 CISPEP 7 PHE A 4 PRO A 5 7 0.01 CISPEP 8 PHE A 4 PRO A 5 8 0.00 CISPEP 9 PHE A 4 PRO A 5 9 0.06 CISPEP 10 PHE A 4 PRO A 5 10 0.14 CISPEP 11 PHE A 4 PRO A 5 11 0.04 CISPEP 12 PHE A 4 PRO A 5 12 0.07 CISPEP 13 PHE A 4 PRO A 5 13 -0.01 CISPEP 14 PHE A 4 PRO A 5 14 0.07 CISPEP 15 PHE A 4 PRO A 5 15 -0.04 CISPEP 16 PHE A 4 PRO A 5 16 -0.01 CISPEP 17 PHE A 4 PRO A 5 17 0.01 CISPEP 18 PHE A 4 PRO A 5 18 -0.05 CISPEP 19 PHE A 4 PRO A 5 19 0.08 CISPEP 20 PHE A 4 PRO A 5 20 0.00 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1